Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2022 (3)
  • 2021 (2)

Subject

  • Prescription Drugs (19)
  • Drug Trafficking (15)
  • Diversion Division (14)
  • Pharmaceuticals/Pharmacists/Physicians (12)
  • Synthetic drugs (9)
  • Seizures (Drugs/Property) (8)
  • Major Law Enforcement Operation (5)
  • Overdose (5)
  • Arrests/Convictions - Major (2)
  • Fake Pills (2)
  • Money Laundering (2)
  • OCDETF/Task Force (2)
  • Take Back Day (2)
  • Dark Web- Internet Trafficking (1)
  • Fentanyl Awareness (1)
  • Guilty Plea (1)
  • Guns/Weapons (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Public and Media Affairs - also see Congressional Affairs (1)
  • Task Forces/Task Force Officers (6)

Drug Name

  • Fentanyl (108)
  • Cocaine (98)
  • Heroin (70)
  • Synthetic Opioids (42)
  • Methamphetamine (41)
  • Opioids (26)
  • Marijuana (Cannabis) (13)
  • Oxycodone (12)
  • Ecstasy/MDMA (4)
  • Morphine (3)
  • Steroids (3)
  • Benzodiazepines (2)
  • K2/Spice (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • Xylazine (2)
  • Amphetamines (1)
  • Ketamine (1)
  • LSD (1)
  • Methadone (1)
  • Hydromorphone (4)
  • Marijuana Concentrates (2)

Field Division

  • Washington, DC (5)
  • Sede (1)
Clear All Results
PRESS RELEASE

Operation Vape Trail Cracks Down on Illegal Substances in Vape Shops

Septiembre 22, 2025
WASHINGTON – Today, the Drug Enforcement Administration announced the results of a week-long operational enforcement action as part of a whole-of-government initiative aimed at removing dangerous and illegal vaping substances from communities across America. During the operation, DEA seized more than 2.3 million vape devices and cartridges and more than...
Septiembre 22, 2025
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

Junio 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
Junio 08, 2022
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

Marzo 04, 2022
DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
Marzo 04, 2022
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

Enero 24, 2022
LYNCHBURG, Va. – A Madison Heights, Virginia man and former veterinarian pleaded guilty to a pair of misdemeanor drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to one count of adulteration of...
Enero 24, 2022
PRESS RELEASE

Leader of Wholesale Drug Distribution Network Pleads Guilty to Distributing Synthetic Cannabinoids and Laundering Millions in Proceeds

Noviembre 02, 2021
ALEXANDRIA, Va. – A Los Angeles man pleaded guilty today to being the head of a conspiracy involving the distribution of wholesale quantities of synthetic cannabinoids—commonly known as “spice” or “K2”—and laundering millions of dollars in the proceeds of the sale of that spice. According to court documents, from 2017...
Noviembre 02, 2021
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

Mayo 12, 2021
ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
Mayo 12, 2021
Showing 1 - 6 of 6 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster